Leal Therapeutics, Inc. has 7 H-1B filings in Massachusetts with $190,000 avg salary. 100% approval rate.
In Massachusetts, Leal Therapeutics, Inc. has sponsored 7 H-1B positions at an average compensation of $190k. The most common roles are Senior Principal Scientist, Nucleic Acid Biology (29%), Principal Scientist, Platform Discovery (29%), Senior Manager, Regulatory Affairs & Quality Assurance (29%). 100% of petitions were certified, with an average processing time of 7 days. Salaries range from $160k to $235k. 14% of positions are for new employment.
| Total Filings | 7 |
| Approval Rate | 100% |
| Average Salary | $190,000 |
| Median Salary | $180,000 |
| 25th Percentile | $170,000 |
| 75th Percentile | $235,000 |
| Minimum Salary | $160,000 |
| Maximum Salary | $235,000 |
| Percentile | Salary |
|---|---|
| 10th | $160k |
| 25th | $170k |
| 50th (Median) | $180k |
| 75th | $235k |
| 90th | $235k |
Based on 7 salary records. Range: $160k – $235k.
100% of filings offer salaries above the prevailing wage, with an average premium of 56%. The average prevailing wage is $125k (based on 7 filings with prevailing wage data).
Average processing time is 7 days (median: 7 days). Fastest: 7 days, slowest: 7 days. Based on 7 filings.
14% of filings are for new positions, while 0% are for continued employment (7 filings with data).
Average contract duration: 36 months (median: 36 months), based on 7 filings.
| Education Level | Filings |
|---|---|
| Not Specified | 7 |
| Job Title | Filings |
|---|---|
| Senior Principal Scientist, Nucleic Acid Biology | 2 |
| Principal Scientist, Platform Discovery | 2 |
| Senior Manager, Regulatory Affairs & Quality Assurance | 2 |
| Principal Scientist, Nucleic Acid Biology | 1 |
Leal Therapeutics, Inc. has 7 H-1B filings in Massachusetts in our database of DOL public records.
The average H-1B salary at Leal Therapeutics, Inc. in Massachusetts is $190,000, with a median of $180,000. Salaries range from $160,000 to $235,000.
Leal Therapeutics, Inc.'s H-1B approval rate in Massachusetts is 100% based on 7 DOL filings.